Peptron (XKRX:087010) Common Stock : ₩10,313 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Peptron Common Stock?

Peptron's quarterly common stock stayed the same from Sep. 2023 (₩10,313 Mil) to Dec. 2023 (₩10,313 Mil) and stayed the same from Dec. 2023 (₩10,313 Mil) to Mar. 2024 (₩10,313 Mil).

Peptron's annual common stock stayed the same from Dec. 2021 (₩10,313 Mil) to Dec. 2022 (₩10,313 Mil) and stayed the same from Dec. 2022 (₩10,313 Mil) to Dec. 2023 (₩10,313 Mil).

Peptron Common Stock Historical Data

The historical data trend for Peptron's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peptron Common Stock Chart

Peptron Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

7,663.25

10,313.43

Peptron Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															10,313.43	10,313.43	10,313.43	10,313.43	10,313.43

Peptron Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Peptron (XKRX:087010) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Peptron Inc (XKRX:087010) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

37-24, Yuseong-daero 1628 beon-gil, Yuseong-gu, Daejeon, KOR, 305811

Website

http://www.peptron.com

Peptron Inc is a biotechnology company engaged in developing fundamental technologies for peptide-based medicines. Its technology includes PeptrEX and SmartDepot. PeptrEX is an automatic system, enabling to synthesize simultaneously from a few to hundred types of peptides. SmartDepot is a proprietary ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of the drug. The group's research and development products include Luphere Depot for the treatment of prostate cancer and endometriosis, SR Exenatide PT302 AND SR EXENATIDE PT304 for the treatment of type II diabetes, SR Exenatide PT320 and 330 for the treatment of Parkinson's and Alzheimer's disease and SR Octreotide for the treatment of acromegaly and carcinoid tumor.

Peptron (XKRX:087010) Headlines

No Headlines